What is BGLC's current stock price?

BGLC (BioNexus Gene Lab Corp.) is currently trading at $2.02 with a market cap of $4.1M.

What sector is BioNexus Gene Lab Corp. in?

BioNexus Gene Lab Corp. (BGLC) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.

InvestLog

BGLC BioNexus Gene Lab Corp.

Healthcare

$2.02-0.25%ClosedMarket Cap: $4.1M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.60

P/S

0.76

EV/EBITDA

-0.11

DCF Value

$-13.18

FCF Yield

-29.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

13.5%

Operating Margin

-54.9%

Net Margin

-54.7%

ROE

-37.4%

ROA

-13.7%

ROIC

-14.3%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$22.8K	$-543.6K	$—
Q4 null	$483.8K	$-1.0M	$—
FY null	$7.4M	$-3.0M	$—
Q3 null	$2.5M	$-709.0K	$—

Trading Activity

Insider Trades

View All

Yew Chak Hua

SellWed Oct 04

Yeoh Sook Keng

SellWed Oct 04

Yap Chee Keong

SellWed Oct 04

Wong Yee Meng

SellWed Oct 04

Teoh Boon Teong

SellWed Oct 04

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

Exchange

—

Beta

2.19

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Peers

APM